Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Japanese labs discontinue compound for perioperative hypertension

Jan. 11, 2002

MC-1 receives FDA approval for entry into phase II

Jan. 10, 2002

Pilot study evaluates Natrecor in chronic heart failure outpatients

Jan. 10, 2002

Vertex moves new drug candidate VX-799 into development for sepsis

Jan. 10, 2002

Patients enrolling in pivotal PRIMO-CABG trial

Jan. 9, 2002

GSK will market Natrecor in Europe under new agreement with Scios

Jan. 8, 2002

IDE filed for Batimastat BiodivYsio stent; enters pivotal phase II trial

Jan. 7, 2002

Sangamo's ZFP technology used to show control of fat cell development

Jan. 7, 2002

Unexpected gene regulatory effects by probucol and BO-653

Jan. 4, 2002

Ibuprofen blocks beneficial effects of aspirin in heart attack prevention

Jan. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...